[{"Assets_0_Q2_USD":293412000.0,"CommonStockSharesOutstanding_0_Q2_shares":37423118.0,"NetIncomeLoss_1_Q2_USD":-70202000.0,"NetIncomeLoss_2_Q2_USD":-126979000.0,"StockholdersEquity_0_Q2_USD":260304000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":37361129.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":37315393.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":37361129.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":37315393.0,"Ticker":"SAGE","CIK":"1597553","name":"SAGE THERAPEUTICS, INC.","OfficialName":"Sage Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2034401653.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]